Keep an eye on SBOT higly undervalued. total Assets almost been doubled $12.8m while total liabilities only 400k, net assets is $12.4m vs $7m Market cap. financed recently.
" The only substantive competition today is biosyn but Stellar is the only KLH manufacturer that can rapidly and reliably ramp production" We continue to calculate fair value of SBOT at $5.50/share".. which is equal to $38.5/ sh a/o today https://t.co/AaCe2OSzei
NIH just picked it...
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.